Physician profile
Marva Lawson
NPI 1801997010
$546.41
in general payments reported to CMS, 2019-2025
7 companies · $26.03 in 2025
The $26.03 reported for 2025 was less than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $64.29 · 2023: $43.00 · 2024: $413 · 2025: $26.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $172.31 | 2024 | Uzedy, Austedo Xr |
| Alkermes, INC. | $151.29 | 2022-2024 | Lybalvi, Aristada |
| Abbvie INC. | $60.95 | 2024-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $60.19 | 2024 | Caplyta |
| Janssen Pharmaceuticals, INC | $48.21 | 2024 | Invega Sustenna, Invega Trinza |
| Neurocrine Biosciences, INC. | $34.98 | 2024 | Ingrezza |
| E.R. Squibb & Sons, L.L.C. | $18.48 | 2024 | Cobenfy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marva Lawson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.